The impact of obesity on pulmonary function in adult women by Costa, Dirceu et al.
719
CLINICS 2008;63(6):719-24
CLINICAL SCIENCE
I Universidade Metodista de Piracicaba (UNIMEP) – Piracicaba/SP, Brazil.
II Hospital Meridional de Cariacica - Cariacica/ES, Brazil.
III Programa de Pós-Graduação em Cirurgia e Experimentação da UNIFESP 
- São Paulo/SP, Brazil.
IV Universidade Federal de São Paulo - São Paulo/SP, Brazil.
Emails: marcelacbarbalho@hotmail.com - dcosta@unimep.br
Tel.: 55 11 27 3346.2000 - Ramal: 2013
Received for publication on April 23, 2008
Accepted for publication on July 30, 2008
ThE ImpACT of obESITy oN puLmoNAry 
fuNCTIoN IN AduLT womEN
Dirceu Costa,I Marcela Cangussu Barbalho,I Gustavo Peixoto Soares Miguel,II,III 
Eli Maria Pazzianotto Forti,I João Luiz Moreira Coutinho AzevedoIV  
 
doi: 10.1590/S1807-59322008000600002
Costa D, Barbalho MC, Miguel GPS, Forti EMP, Azevedo JLMC. The impact of obesity on pulmonary function in adult 
women. Clinics. 2008;63:719-24.
INTRODUCTION: Obesity can cause deleterious effects on respiratory function and impair health and quality of life. 
OBJECTIVE: To evaluate the effects of obesity on the pulmonary function of adult women. 
METHODS: An obese group, constituted of 20 women between 20 and 35 years old with a BMI of 35 - 49.99 kg/m2 who were 
non-smokers and sedentary and had no lung disease were recruited. The non-obese group consisted of 20 women between 20 and 
35 years old who were sedentary and non-smokers and had no lung disease and a body mass index between 18.5 and 24.99 kg/m2. 
Spirometry was performed in all subjects. The statistical analysis consisted of parametric or non-parametric tests, depending on 
the distribution of each variable, considering p < 0.05 to be statistically significant. 
RESULTS: The obese group presented a mean age of 25.85 ± 3.89 years and a mean BMI of 41.1 ± 3.46 kg/m2, and the non-obese 
group presented a mean age of 23.9 ± 2.97 years and a mean body mass index of 21.91 ± 1.81 kg/m2. There were no significant 
differences between the obese group and the non-obese group as to the age, vital capacity, tidal volume, forced vital capacity, and 
forced expiratory volume in one second. However, the obese group presented a greater inspiratory reserve volume (2.44 ± 0.47 L 
vs. 1.87 ± 0.42 L), a lower expiratory reserve volume (0.52 ± 0.32 L vs. 1.15 ± 0.32 L), and a maximal voluntary ventilation 
(108.5 ± 13.3 L/min vs. 122.6 ± 19.8 L/min) than the non-obese group, respectively. 
CONCLUSION: The alterations evidenced in the components of the vital capacity (inspiratory reserve volume and expiratory 
reserve volume) suggest damage to the chest mechanics caused by obesity. These factors probably contributed to a reduction of 
the maximal voluntary ventilation.
KEYWORDS: Body Mass Index; Chest Mechanics; Spirometry; Pulmonary Volumes; Maximal Voluntary Ventilation.
INTRODUCTION 
Obesity is a chronic disease characterized by excessive 
body fat that causes damage to the individual’s health1,2 
and is associated with comorbidities such as diabetes3 
and hypertension.3,4 and vascular dysfunction5,6 Obesity in 
adults is defined by the World Health Organization (WHO) 
as having a body mass index (BMI) that is greater than or 
equal to 30 kg/m2.2 The normal BMI range is between 18.5 
and 24.99 kg/m.24 
Currently, there are estimated to be one billion 
overweight adults, and at least 300 million of them suffer 
from clinical obesity.7,8 It was recently published that, in 
Brazil, 41.1% of men and 40.0% of women are overweight; 
8.9% and 13.1%, respectively, are obese.9 
Obesity can cause various deleterious effects to respiratory 
function, such as alterations in respiratory mechanics, decrease 
in respiratory muscle strength and endurance, decrease 
in pulmonary gas exchange, lower control of breathing, 
and limitations in pulmonary function tests and exercise 
capacity.10-14 These changes in lung function are caused by 
extra adipose tissue in the chest wall and abdominal cavity, 
compressing the thoracic cage, diaphragm, and lungs. The 
consequences are a decrease in diaphragm displacement, a 
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decrease in lung and chest wall compliance, and an increase 
in elastic recoil, resulting in a decrease in lung volumes and an 
overload of inspiratory muscles.11 These changes are worsened 
by an increase in the BMI.15
Since morbid obesity is always associated with various 
other alterations, especially those of pulmonary origin, it 
becomes necessary to assess the respiratory function of 
obese individuals. This helps to identify and treat these 
changes at an early stage in order to prevent negative effects 
on health and quality of life. Therefore, the objective of this 
study was, by comparing obese and non-obese subjects, to 
evaluate the impact of obesity on the pulmonary function of 
adult women with no history of pulmonary disease.
METHODS 
From March to October 2007, 20 sedentary women ages 
20 to 35 years old who were non-smokers, showed no history 
of lung diseases, had a BMI between 35 and 49.99 kg/m2, and 
were on a waiting list for bariatric surgery at the Merdional 
Hospital, were selected to comprise the obese group (OG). 
To compose the non-obese group (NOG), 20 sedentary and 
healthy female university students aged between 20 and 
35 years old who were non-smokers, presented no lung 
disease, and had a BMI ranging from 18.5 to 24.99 kg/m2 
were selected. Patients showing obstructive or restrictive 
alterations in the pulmonary function tests, obstructive 
sleep apnea syndrome, and an inability to perform the tests 
adequately were excluded. The patients signed an informed 
consent term, and the study was approved by the UNIMEP 
Ethics Committee, protocol number 68/06. 
The evaluation of pulmonary function was performed by 
conventional spirometry using an EasyOneTM (Model 2001) 
computerized spirometer (ndd Medizintechnik AG, Zurich, 
Switzerland). The directly evaluated parameters were lung 
volumes, capacities, and flows through the procedures of 
Slow Vital Capacity (SVC), Forced Vital Capacity (FVC), 
and Maximal Voluntary Ventilation (MVV), performed in 
this order at least three times each, according to the standards 
of the American Thoracic Society (ATS) and the European 
Respiratory Society (ERS) (2005),16 with volunteers in the 
sitting position. Results were expressed as absolute values 
and as percentages of the reference predicted values from 
Pereira et al.17 (1992). By means of the SVC procedure, it 
was possible to obtain the following variables: vital capacity 
(VC), tidal volume (VT), inspiratory reserve volume (IRV), 
and expiratory reserve volume (ERV). The FVC procedure 
allowed for the determination of the forced expiratory 
volume in one second (FEV1) and the FEV1/FVC ratio. The 
MVV was expressed in L/min and as percentages of the 
reference predicted value.
Patients were questioned regarding the presence 
of comorbidities such as hypertension, diabetes, and 
dyslipidemia. Moreover, the sensation of dyspnea was 
evaluated in obese patients using the Medical Research 
Council (MRC)18 scale, which consists of five questions 
based on the degrees of various physical activities that lead 
to breathlessness. A patient’s dyspnea is classified according 
to the following grades: absent (0), light (1), moderate (2), 
moderate / severe (3), and severe (4). 
The data were submitted to the Shapiro-Wilk test, and 
once a normal distribution was confirmed, the independent 
t-test was applied. A significance level of p ≤ 0.05 was 
considered for all tests. The Pearson’s correlation was used 
to show a relationship between the variables BMI, IRV, ERV, 
and MVV. The study of the sample size showed a power 
≥ 80% for p ≤ 0.05.
RESULTS
As shown in Table 1, the obese and non-obese groups did 
not differ in age. However, the OG showed a higher BMI, 
as expected. In the NOG, there were no patients presenting 
comorbidities, while in the OG, seven patients showed 
dyslipidemia and four presented hypertension. None of the 
patients was diabetic. The dyspnea score (MRC) was 0.85 ± 
0.49 (grade 0 - n = 4, grade 1 - n = 15, grade 2 - n = 1).
Concerning the spirometric variables (Table 1), there 
were no statistical differences between groups for the VT, 
VC, FVC, and FEV1. The OG showed a higher IRV and 
lower ERV compared with the NOG. The MVV was lower in 
the OG. The groups were statistically different for the FEV1/
FVC ratio, but all were within the normal values; therefore, 
none of the patients showed obstructive or restrictive 
pulmonary disorder (Table 1).
When correlating the IRV with the BMI, a moderate 
positive correlation (r = 0.50) (p = 0.0011) was observed 
(Figure 1). 
When correlating the BMI with the ERV and the MVV, 
a strong negative correlation with the former (r = - 0.69) 
and a moderate correlation with the latter (r = - 0.38) were 
observed, both showing statistical significance (p < 0.01) 
(Figures 2 and 3). 
A strong positive correlation between the ERV and the 
MVV (r = 0.59), showing a statistical significance (p < 
0.0001), was also observed when both groups were evaluated 
(Figure 4).
DISCUSSION 
Among the harmful effects of obesity to health, the 
respiratory changes represent an additional factor of 
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Table 1 - Age, body mass index (BMI), and spirometric variables of obese and non-obese groups
Variables OBESE GROUP (n=20) NON-OBESE GROUP (n=20) p
AGE (years) 25.85 ± 3.89 23.90 ± 2.97 ns
BMI (kg/m2) 41.11 ± 3.47 21.92 ± 1.82 <0.0001
FVC (L) 3.80 ± 0.55 3.77 ± 0.55 ns
%FVC 100.80 ± 11.81 98.25 ± 9.21 ns
FEV1 (L) 3.10 ± 0.43 3.33 ± 0.44 ns
%FEV1 95.75 ± 11.16 100.05 ± 8.44 ns
FEV1/FVC 0.83 ± 0.04 0.89 ± 0.04 < 0.01
VC (L) 3.74 ± 0.59 3.71 ± 0.64 ns
%VC 99.12 ± 12.96 96.45 ± 10.60 ns
TV(L) 0.77 ± 0.20 0.69 ± 0.25 ns
IRV (L) 2.44 ± 0.47 1.87 ± 0.42 < 0.001
ERV (L) 0.52 ± 0.32 1.15 ± 0.32 < 0.001
MVV (L/min) 108.50 ± 13.30 122.60 ± 19.80 < 0.01
%MVV 92.70 ± 9.08 102.95 ± 13.32 < 0.01
FVC: forced vital capacity; % FVC: percentage of predicted FVC values; FEV1: forced expiratory volume in one second, % FEV1: percentage of predicted 
VEF1 values; MVV: Maximum voluntary ventilation; % MVV: percentage of predicted MVV values; VC: vital capacity; % VC: percentage of predicted 
VC values; TV: tidal volume; IRV: inspiratory reserve volume; ERV: expiratory reserve volume; ns: not significant. 
Figure 1 - Correlation between the body mass index (BMI) and the inspira-
tory reserve volume (IRV)
functional limitation and detriment to the quality of life of 
obese individuals. In assessing the impact of obesity on the 
pulmonary function of adult women who were non-smokers 
and presented no history of lung disease or prior changes 
in the pulmonary function tests, important and significant 
differences were found between obese and non-obese 
subjects for the ERV, IRV, and MVV. According to the 
results, such differences can be attributed to obesity.
One of the most significant findings regarding changes 
in ventilation caused by obesity was the reduction in the 
ERV11-15,19 confirmed by our results. A negative correlation 
was observed between the BMI and the ERV. Jones and 
Nzekwu15 (2006) reported a reduction in the functional 
residual capacity (FRC), suggesting that the ERV reduces 
5% per unit of increase in BMI and that, above 30 kg/m2, it 
reduces 1% per unit of BMI. According to Koenig11 (2001), 
this fact is attributed to the reduction of the diaphragm 
mobility in the chest, as the diaphragm is pressed upwards 
due to the expanded abdominal volume of obese individuals, 
a mechanical disadvantage for this muscle. Another factor 
Figure 2 - Correlation between the body mass index (BMI) and the expira-
tory reserve volume (ERV)
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that may lead to the reduction in the ERV is the pulmonary 
compliance due to obesity.20 Besides these detrimental 
mechanical aspects to the pulmonary function of obese 
individuals, Young et al.21 (2003) suggested that the reduction 
of the ERV can lead to the increase of areas of atelectasis, 
harming the ventilation/perfusion mismatch and leading to 
arterial hypoxemia in those individuals.
Some authors have suggested that obesity may promote 
air trapping, which impairs adequate pulmonary ventilation 
through the reduction of pulmonary volumes.12,22 Teixeira et 
al.22 (2007) showed an increase in the residual volume (RV) 
associated with the reduction in the ERV in obese subjects 
who had dyspnea complaints. The authors suggested that the 
reduction in the ERV can be attributed to the obstruction of 
small airways and a consequent reduction in gas exchange. 
Ladosky, Botelho, and Albuquerque12 (2001), comparing 
a group of obese and non-obese patients, also suggested 
that the reduction of the ERV may be a consequence of 
air trapping caused by obesity and leading to a reduction 
in the MVV. Although our methodology did not assess the 
extent of air trapping, it was observed that, in addition to the 
reduction in the ERV, there was also a reduction in the MVV. 
These variables showed a highly significant and positive 
correlation. 
The MVV test evaluates the respiratory endurance and is 
influenced by the respiratory muscle strength, the lung and 
chest compliance, and the control of breathing and airway 
resistance.12,23 In the case of obese individuals, this variable 
is reduced mainly by mechanical injury to the respiratory 
muscles, caused in particular by the excessive weight on the 
thorax.12 
The increase in the IRV in obese individuals is not 
a common finding, but it was already reported by some 
authors.11,12 Rasslan et al.12 (2004) showed that the inspiratory 
capacity (IC) was higher in obese individuals than in non-
obese ones, even when all the other spirometric values were 
within the normal range. These authors suggested that this 
fact may indicate normal lung compliance and an ability of 
the respiratory muscles to compensate, though temporarily, 
for the excess weight on the chest and abdomen. According 
to our results, no differences were observed between obese 
and non-obese individuals for the VC and VT. However, obese 
individuals showed a reduction in the ERV, possibly offset 
by the increase in the IRV, thus keeping the VC unchanged. 
These findings suggest that obesity causes injury to ventilatory 
mechanics (reducing the ERV) and that these changes seem 
to generate overload to the accessory inspiratory muscles that 
work to compensate the ventilation (i.e., increase IRV).
It has been suggested that obesity causes overload to the 
accessory respiratory muscles and that these muscles are 
primarily responsible for the dyspnea reported by the obese 
group.13,24 El-Gamal et al.24 (2005) found, in obese patients 
waiting for bariatric surgery, an increase in the respiratory 
drive associated with the more serious complaints of dyspnea 
and a reduction in static lung volumes. When assessing the 
same patients one year after the surgery, it was observed that 
the reduction in weight also reduced the respiratory drive and 
dyspnea complaints. This increased overload on accessory 
respiratory muscles caused by obesity may indirectly 
contribute to the increase in the IRV, thus maintaining the VC. 
However, the overload was not enough to cause major dyspnea 
in the patients studied. Other authors found a connection 
between obesity and dyspnea when studying a group of 
patients older than ours and with higher BMI levels.22,24
Figure 4 - Correlation between the expiratory reserve volume (ERV) and 
the maximum voluntary ventilation (MVV)
Figure 3 - Correlation between the body mass index (BMI) and the maximum 
voluntary ventilation (MVV)
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According to recent studies, the reduction in lung volume 
in obese people is not only directly related to the increase in 
the BMI; it is also related to the distribution of body fat.10-12 
Ochs-Balcom et al. (2006)25 stated that abdominal adiposity 
contributes to impairment of lung function and is even more 
important than general adiposity markers such as weight 
and BMI. Once body fat is more peripherally distributed in 
women and more centrally distributed in men, pulmonary 
function is also affected according to gender, as verified 
by some authors.12,17,25 Hence, only women patients were 
selected. New studies are needed in order to find out whether 
the results observed in this study can be applied to men. 
CONCLUSIONS 
Based on our results, we can conclude that obesity causes 
significant changes in respiratory function, as is evidenced 
by the highlighted changes in the components of the VC 
(IRV and ERV). These findings suggest deleterious effects 
on ventilatory mechanics caused by obesity, due to probable 
lung compression (reduction in the ERV), leading to a 
compensatory increase in the IRV in an attempt to maintain a 
constant VC. Harming the ventilatory mechanics associated 
with ERV reduction may have contributed to the reduction 
in the MVV. However, these changes were not sufficient 
to cause obstructive or restrictive pulmonary disorders by 
spirometry or significant breathlessness complaints in obese 
women with a BMI between 35 and 49.99 kg/m2. 
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